Acute Pancreatitis: Initial Management
|
|
- Simon Carter
- 7 years ago
- Views:
Transcription
1 Acute Pancreatitis: Initial Management Algorithm 1. Recognition and Initial Severity Assessment Presentation suggestive of acute pancreatitis Medical History Physical Exam Labs to Order Imaging Investigate: Risk Factors/ Etiologies Predictors of severity See section 2.2 in text Epigastric pain, nausea, vomiting Restlessness, fever, tachycardia If severe, may see marked tenderness with guarding, abdominal distension, absent bowel sounds, signs of shock, jaundice, signs of pulmonary involvement CBC (Hct key) Chem10 Amylase, lipase LFTs Lipid panel LDH ABG, lactate if critically illappearing See section 2.3 in text Chest XR and/or Abd XR CT abdomen is not indicated on presentation except in crtically ill patients Acute Pancreatitis is confirmed by these defining characteristics Clinical symptoms of epigastric abdominal pain, nausea, and vomiting and Elevation in amylase and/or lipase 3 times the upper limit of normal CT imaging is not indicated to confirm the diagnosis and should not be performed until hours after symptom onset except in select patients See section 2.4 in text for indications Severity Assessment and Triage Appropriate triage to general floor VS PCU/ICU is essential Acute pancreatitis always warrants admission Severity assessment should be based on the presence of any these factors: Subjects with < 2 factors AND Severity Assessment Model score in the mild range Mild Acute Pancreatitis Presence of multiple comorbidities Presence of SIRS criteria Hct > 44 or failure to decrease by 10% in first 24 hours Elevated BUN or Cr or failure to decrease by 10% in first 24 hours Hypoxia Lactate > 4 mmol Pleural effusion on CXR CT or MRI showing evidence of severe pancreatitis and/or necrosis Severity assessment model score suggesting severe pancreatitis Severity assessment models can also be used: Severity Assessment Ranson Criteria APACHE II BiSAP Scoring System on Admission within 24 hrs Mild Pancreatitis < 3 < 6-8 < 3 Severe Pancreatitis > 3 > 6-8 > 3 Subjects with 2 factors OR Severity Assessment Model score in the severe range Severe Acute Pancreatitis Admission to a general floor is appropriate Serial monitoring for deterioration is essential. Telemetry,SatO2, urine output, frequent vitals and labs Serial Severity Assessment Score calculation Maintain a low threshold to escalate the level of care with any signs of deterioration or lack of improvement Consider admission to PCU/ICU Consideration for pancreatic surgery complications
2 Algorithm 2. Acute Pancreatitis Management 2 Mild Acute Pancreatitis 0-24 hours: Obtain 2 peripheral 18-gauge IVs Control pain and nausea Make NPO Labs: CBC, Chem10, Amylase, lipase, LFTs, Lipid panel, LDH Focus on aggressive rehydration: IVF challenge of 1-2 liters NS if no clinical contraindications IVF at 250 ml/hr of NS or D 5 -½ NS until adequate urine output is achieved Severe Acute Pancreatitis 0-12 hours: Obtain 2 peripheral 18-gauge IVs or central line Make NPO Control pain and nausea Labs: CBC, Chem10, Amylase, lipase, LFTs, Lipid panel, LDH, ABG, lactate Focus on aggressive rehydration: IVF challenge of 1-3 liters NS or LR if acidosis (over min) if no clinical contraindication IVF at ml/hr of NS or LR Calculate severity assessment scores Monitor closely for signs of deterioration: If urine output < 0.5 ml/kg/hr or oxygen requirement increasing, consider CVP placement Failure of Hct/BUN to decrease in 6-12hrs Urine output <0.5 ml/kg/hr Increasing oxygen requirements Altered renal status No Hours Yes Hours Continue aggressive fluid rehydration: IVF at ml/hr of NS or D 5 -½ NS until adequate urine output is achieved Treat supportively and prevent infection, minimize lines, avoid TPN NPO Ensure adequate pain control Prophylactic antibiotic use is not warranted in the absence of biliary sepsis or obvious pancreatic/peri-pancreatic infection (See algorithm #3) Consider Abdominal ultrasound Consider emergent ERCP or MRCP / EUS if evidence of cholangitis (See section 4.3 in text) Consult gastroenterology (hepatobiliary) and general surgery Calculate severity assessment scores Check CRP Continue IV hydration and pain control Hours Severity assessment model labs and RUQ ultrasound If anticipate NPO status for > 7 days, begin jejunal enteral nutrition Do not follow amylase/lipase daily as levels do not correlate with severity See sections 4.2 and 4.3 in text for indications for ERCP, MRCP, and EUS. If scores in severe range OR signs of clinical worsening consider transfer to PCU/ ICU Urine output < 0.5 ml/kg/hr or Oxygen requirement increasing No Yes Consider rapid bolus CT to assess for evidence of pancreatic necrosis (See sections and 4.2 in text) Begin enteral nutritional support within 2-3 days in severe acute pancreatitis; jejunal feeding is preferred TPN is reserved for those unable to tolerate enteral feeds Consider urgent ERCP if evidence of evidence of biliary obstruction (See section 4.3 in text) Calculate severity assessment scores If patient does well after first 48 hrs in PCU/ICU, or recovers from acute illness with no further concern for organ failure, consider transfer out of PCU/ICU 72 Hours If clinically decompensating, suspect infected necrosis (See algorithm #3) Pancreatic Surgery Consultation Guided antibiotics (See section 4.4 in text)
3 Algorithm 3. Pancreatic Necrosis 3 Suspected Pancreatic Necrosis If < 30% non-enhancement Rapid Bolus Contrast Enhanced CT Scan at hours If 30% non-enhancement or clinically declining Conservative Management IV fluids, aggressive rehydration, and pain control If unable to obtain CT-FNA, and high clinical suspicion of infection Consider starting empiric antibiotics with pancreatic penetration Piperacillin and tazobactam or cefepime + metronidazole, or high-dose cephalosporins Obtain CT-guided FNA (Generally 7-10 days after admission) Send for gram stain and culture Sterile Necrosis Negative Gram Stain or Culture Supportive Care and prevention of infection Minimize IV lines, avoid TPN, NPO, and start enteral nutrition Repeat CT-guided FNA every 5-7 days as clinically indicated Infected Necrosis Positive Gram Stain or Culture Begin empiric antibiotic coverage Tailor antibiotics based on GS/culture Clinically Stable Clinically Unstable Conservative Management Continue IV antibiotics for 2-4 weeks prior to elective surgery (cholecystectomy) Consider prompt surgical debridement Clinical decompensation
4 4 1. Etiologies In Order of Prevalence Biliary (choledocholithiasis, gallstones). Acute alcohol consumption. Medications including: acetaminophen, azathioprine, erythromycin, 6-mercaptopurine, estrogen, exenatide, furosemide, metronidazole, NSAIDs, pentamidine, stavudine, sulindac, tetracycline, and valproic acid. Anatomic or functional disorders (sphincter of Oddi dysfunction, congenital anomalies [e.g., pancreatic divisum], pancreatic or ampullary tumors). Infectious (e.g., viral, bacterial, parasitic, fungal). Traumatic or post-procedure (e.g., post-ercp or abdominal surgery). Autoimmune (e.g., systemic lupus erythematosus). Metabolic derangements: hypercalcemia, hypertriglyceridemia, severe acidosis (DKA). Hypothermia. Genetic: cystic fibrosis (CFTR), trypsinogen gene (PRSS1), pancreatic secretory trypsin inhibitor gene (SPINK1 recurrent disease only). Vascular (e.g., vasculitis, ischemia). Toxins - ethyl alcohol, organophosphates, scorpion bite. Idiopathic. 2. Diagnosis and Workup 2.1 Definition of Acute Pancreatitis: Two of the following: Clinical symptoms of epigastric abdominal pain, nausea, and vomiting. Elevation in amylase and/or lipase 3 times the upper limit of normal. Imaging confirmation of pancreatitis on CT or MRI. 2.2 History and Physical Focus on identifying risk factors such as heavy alcohol use, family history of gallstones or pancreatitis, medications, etc. Focus on identifying predictors of severity such as dehydration, septic appearance, elderly patients, etc. 2.3 Labs to Order On Admission: CBC (hematocrit is key) Elevated levels may indicate higher risk of developing necrotizing pancreatitis. Creatinine (> 2 mg/dl) and blood glucose > 250 mg/dl are significantly correlated with mortality. Amylase, lipase. Liver Functional Panel AST/ALT > 3 times normal, highly suggestive of gallstones as etiology. Calcium -- Levels < 6.6 mg/dl may be suggestive of more severe disease. ABG If patient is critically ill-appearing. At 48 hours: CRP Extremely useful at both 24 hours (if trending upwards) and 48 hours after symptom onset as a predictor of severe disease. o Check if patient not improving with conservative management or if clinically decompensating. o CRP > 150 mg/l suggestive of more severe disease. Check labs for severity assessment model calculations: Chem10, LFTs, CBC w/ diff, LDH, coagulation factors, and ABG 2.4 Imaging Indications for CXR: if ill-appearing or if exam concerning for pleural effusions. o Pleural effusion or infiltrate within 24 hours associated with increased mortality risk, necrotizing pancreatitis, and the development of infected necrosis. Indications for early CT imaging (rapid bolus contrast-enhanced CT): o Generally, CT imaging not indicated until hours after symptom onset except in select patients: If patient is critically ill or questionable diagnosis, if high clinical suspicion but amylase/ lipase less than 3 times the upper limit of normal, or in patients with progressively worsening symptoms. o Advantages of CT: High sensitivity for detection of necrotizing pancreatitis, presence of peri-pancreatic inflammation, and fluid collections. The extent of necrosis may predict disease severity and outcome Allows calculation of CT Severity Index (see appendix for details).
5 5 o Limitations of CT: Early imaging may underestimate the amount of necrosis present. IV contrast may be associated with worse outcomes as it may exacerbate microcirculatory hypoperfusion and worsen necrosis. Notes: These are additional tests that have been studied with data showing utility in predicting disease severity, but not enough clinical data exists to recommend their use at this time: On admission - IL-6 ELISA, cutoff level > 400 pg/ml; IL-8; Trypsinogen activation peptide. At 24 hours - PMN-elastase levels > 300 ug/l suggestive of more severe disease; Phospholipase A 2, Procalcitonin (indicates necrosis if elevated); Urinary T-2 ELISA, cutoff level >35 nmol/l; Urinary trypsinogen activation peptide dipstick, cutoff level >2000 ng/l. 3. Severity Assessment Appropriate triage (to General Floor VS PCU/ICU) is essential in the management of acute pancreatitis. Acute pancreatitis always warrants admission. Acute pancreatitis initially diagnosed as mild or moderate can rapidly progress to severe or even fatal illness: o Prognostic indicators are not reliable in the first 24 hours o In any level of acute pancreatitis appropriate nursing care, continuous monitoring, and serial assessments are essential 3.1 Indications for PCU/ICU Consideration: High risk patients are best cared for in an ICU setting. ICU admission should be considered for subjects with 3 of the following: o Presence of multiple co-morbidities o Presence of SIRS criteria o Hypoxia o Hct > 44 or failure to decrease by 10% in first 24 hours o Elevated BUN or Cr or failure to decrease by 10% in first 24 hours o Presence of multiple comorbidities o Presence of SIRS criteria o Hypoxia o Hct > 44 or failure to decrease by 10% in first 24 hours o Elevated BUN or Cr or failure to decrease by 10% in first 24 hours o Pleural effusions on CXR o CT or MRI showing evidence of severe pancreatitis and/or necrosis o Severity assessment model scores suggesting severe pancreatitis Reversal of organ failure in first 48 hours is critical for improved outcomes. If patient does well after first 48 hours in PCU/ICU with no further concern for organ failure, can consider transfer out. 3.2 Indications for Admission to the General Floor Lack of the above. o Serial monitoring for deterioration is essential Telemetry, continuous pulse oxymetry, frequent vitals and labs, serial assessments. o Maintain a low threshold to escalate the level of care and transfer to PCU/ICU. 3.3 Prognostic Scoring Systems for Acute Pancreatitis and Links to Calculators (see Table 1 in the appendix for details) Ranson Score - BiSAP see appendix APACHE II Score CT Severity Index see appendix 4. Management 4.1 Resuscitation - On Admission Follow steps above in Diagnosis and Workup. Make patient NPO, and control of nausea and pain. o NSAIDs, IV narcotics, and patientcontrolled administration of analgesia are all acceptable. Use of hydromorphone (Dilaudid ) is acceptable; avoid tramadol due to side effects of nausea/vomiting. No data exist that any one medication is preferred over another.
6 First 6-12 hours. Most critical time - Focus on vigorous fluid resuscitation hours: ml/hr NS or D5-1/2NS is the minimum; likely will need more if overall volume depleted. o Bolus 1-2 liters of NS on admission based on clinical presentation. Titrate hydration to decrease Hct by at least 10% and decrease BUN in first 6-12 hours. o Adjust fluid rate q1-4 hours based on serial labs and assessments (urine output, vitals, Hct, BUN). Goal urine output is 0.5 ml/kg/hr. Rate may need to be adjusted in patients with renal, pulmonary, or cardiac co-morbidities. o If unclear ARDS vs volume overload, consider transfer to ICU for intra-cardiac monitoring or intubation. Monitor closely for clinical worsening, failure of Hct/BUN to decrease in first 6-12 hours, or signs of organ failure. o If any of the above develop, consider transfer to PCU or ICU. o Consider imaging hours: If patient clinically worsening, check CRP and labs to calculate severity assessment model scores. If Ranson Score > 3 or APACHE II Score 6-8, consider transfer to PCU/ICU; consult GI (hepatobiliary) / general surgery. 4.2 Indications for ERCP Emergent (within 24 hours): suspicion for ascending cholangitis. Urgent (within hours): severe acute pancreatitis (APACHE II score 8 or persistent illness refractory to supportive care); evidence of biliary obstruction, or elevated bilirubin levels, > 3-fold elevation in AST/ALT, or when patient refractory to conservative management. Late (after 72 hours): sphincterotomy is an alternative to cholecystectomy in non-surgical candidates. 4.3 Indications for MRI / MRCP or EUS To avoid unnecessary ERCP when persistent biliary obstruction is suspected and no radiological (U/S or CT) evidence of CBD abnormalities. Persistently elevated LFTs. To differentiate between pseudocysts and walledoff pancreatic necrosis. 4.4 Severe Pancreatitis with/without Evidence of Necrosis: Patient should be in PCU/ICU. o Continue vigorous fluid ressuscitation ( ml/hr NS). o Obtain imaging to evaluate for severe pancreatitis and/or evidence of pancreatic necrosis. Pancreatic Necrosis: Defined as gross destruction of the pancreatic gland, which is seen in 20% of patients. It is diagnosed by the presence of 30% of non-enhancement on rapid bolus contrast-enhanced CT. o Usually occurs within the first 4 days of the onset of symptoms. o Considered sterile early in course, but can become infected later both can lead to organ failure. Sterile Necrosis. Treat supportively and prevent infection. o Minimize IV lines, avoid TPN, strict NPO and start enteral nutrition. o Prophylactic antibiotic use in the absence of biliary sepsis or obvious pancreatic/peripancreatic infection is not warranted. o Surgery has no proven benefit in sterile necrosis. Infected Necrosis: 33% of those with sterile necrosis develop infection; usually clinically apparent after days of illness. Infected pancreatic necrosis is rare before 14 days. o Look for signs of sepsis and persistent organ failure. o Obtain CT-guided FNA gram stain is 95% sensitive for diagnosis. o Prompt surgical necrosectomy is mandatory for all patients with infected pancreatic necrosis. If strongly suspected: Positive CT guided culture o Emphazematous pancreatitis on imaging Clinical deterioration despite adequate medical therapy. If infected, start pancreatic penetrating antibiotics: piperacillin and tazobactam or cefepime + metronidazole, or high-dose cephalosporins. If unable to obtain CT and strong suspicion of infection, start antibiotics (see algorithm 3 for decision tree). 6
7 4.5 Nutritional Concerns. Critical; pancreatitis leads to a catabolic state and nutritional deterioration. Enteral Nutrition always preferred; Naso-jejunal feeding is preferred; less risk of infection or complications. o Mild Acute Pancreatitis: start enteral nutrition if suspect > 7d NPO status. Nutritional support is usually unnecessary. Resume oral diet when enzymes normalize and symptoms resolve. o Severe Acute Pancreatitis: trial enteral feeds within the first 2-3 days; consider TPN only if patient is unable to tolerate enteral feeding. Consider resuming oral nutrition when clinical improvement is demonstrated by resolving pain the desire to eat. 5. Complications Consider consultation with gastroenterology (hepatobiliary) and pancreatic surgery. o Definitive surgery for biliary pancreatitis (cholecystectomy) should be performed during the same admission if possible. Atlanta classification terminology preferred (see reference). 5.1 Infected Necrosis Suspect in patients with preexisting sterile pancreatic necrosis who have persistent or worsening symptoms or who develop signs/ symptoms of infection, typically 7-10 days after illness. Culture and gram stain of fluid should guide antibiotic therapy. 5.2 Vascular Leak Syndrome Complication of SIRS/sepsis that can result in intravascular depletion, hemoconcentration, hypotension, renal insufficiency, pulmonary edema, ARDS, and shock. Multiorgan dysfunction or failure associated with SIRS is a leading cause of morbidity and mortality during the first week of severe acute pancreatitis. 5.3 Hyperglycemia Patients without a history of diabetes may experience moderate hyperglycemia during severe pancreatitis. Administer insulin cautiously because of volatility in the serum glucose level, the potential for a blunted pancreatic release of glucagon in response to hypoglycemia, and the frequently transient nature of the serum glucose abnormalities. 5.4 Hypocalcemia Commonly occurs with severe acute pancreatitis. o Primarily secondary to precipitation of calcium soaps in the abdominal cavity. o Management: Quickly correct symptomatic or severe hypocalcemia with cardiac arrhythmias or tetany with calcium gluconate or calcium chloride. Administer 1-2 ampules 10% calcium gluconate (93 mg/10 ml) in ml of D5W over 5-10 minutes. Calcium chloride10% solution (273 mg/10-ml ampule) delivers higher amounts \of calcium and is advantageous when rapid correction is needed, but it should be administered via central venous access. Measure serum calcium every 4-6 hours to maintain serum calcium levels at 8-9 mg/dl. If low albumin is also present, monitor ionized calcium. If calcium remains low despite calcium supplementation: rule out hypomagnesemia. 5.5 Fluid Collections and Pseudocysts Intraabdominal fluid collections can persist and form a fibrinous wall in 33% of cases. It cannot be called a pseudocyst if identified in the first 2-3 weeks after the onset of symptoms. o The differential diagnosis includes: Walled-Off Pancreatic Necrosis (WOPN): a local complication of acute necrotizing pancreatitis, occurring more than 4 weeks after the initial attack. They represent enzyme-rich fluid that can walled off by granulation tissue or bacterial seeding of pancreatic or peripancreatic tissue Pseudocyst: Peripancreatic fluid encased in a fibrinous capsule. Cystic neoplasm: particularly if no history of chronic pancreatitis. Important to differentiate between walled-off pancreatic necrosis (WOPN; always involves pancreas) and pseudocysts (outside pancreatic parenchyma): o MRI/MRCP or EUS are more sensitive than CT for differentiation. o Treatment of an infected pseudocyst (abscess) is different than pancreatic necrosis. 7
8 8 5.6 Recurrent Pancreatitis Prevention References Order Sets Alcoholic pancreatitis: refer to counseling services and smoking cessation services, if applicable. Gallstone pancreatitis: o If mild pancreatitis: attempt surgery during same admission. o If severe: delay surgery until sufficient resolution of inflammation and clinical recovery. o If non-surgical candidate: endoscopic sphincterotomy is an alternative to cholecystectomy. AGA Institute medical position statement on acute pancreatitis. Gastroenterology (5): Curtis C. and Kudsk KA. Nutrition support in pancreatitis. Surg Clin North Am (6): , viii. Isenmann R, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology (4): UK Guidelines for the management of acute pancreatitis. Gut Suppl 3:iii1-9. Papachristou, G. I., V. Muddana, et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol (2):435-41; quiz 442. Uhl W, et al. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002;2: Banks PA, Freeman ML and the Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101: Revision of the Atlanta Classification of Acute Pancreatitis. Acute Pancreatitis Classification Working Group. April 9, H:/MGSarr/Documents/Atlanta Classification.doc. OSU IP GE: ADM ACUTE PANCREATITIS [2191] OSU IP ED: CDU/OBS PANCREATITIS [2491] Quality Measures Documentation of severity Percent of patients with pancreatitis diagnosis who are transferred to the ICU Percent of patients with a CT within first 48 hours of admission/arrival (non-icu vs. ICU patients) Percent of patients readmitted within 30 days Mortality rate Guideline Author Maher Azzouz, MD Guideline Approved Disclaimer July 24, Second Edition Clinical practice guidelines and algorithms at The Ohio State University Wexner Medical Center (OSUWMC) are standards that are intended to provide general guidance to clinicians. Patient choice and clinician judgment must remain central to the selection of diagnostic tests and therapy. OSUWMC s guidelines and algorithms are reviewed periodically for consistency with new evidence; however, new developments may not be represented. Copyright The Ohio State University Wexner Medical Center. No part of this publication may be reproduced in any form without permission in writing from The Ohio State University Wexner Medical Center
9 Appendix Severity Risk Model Calculations 9 Risk Score Type Ranson Score Notes Scoring Interpretation Link to calculators Five of these signs measured on admission The remaining six are measured at 48 hours into the hospital course At admission or diagnosis: Age > 55 years WBC > 16,000 Blood glucose > 200 mg/dl LDH > 350 U/L AST > 250 U/L During initial 48 hours: Hct decreases > 10% BUN increases > 5 mg/dl Serum Ca < 8mg/dL Base deficit (24 HCO3) > 4 meq/l Fluid needs > 6L within 48h of admission PaO2 < 60 mm Hg 1 point for each criterion met Score 3 at 48 hours: Major complications, severity, organ failure, pancreatic necrosis, mortality, longer hospital stay. Severe pancreatitis is likely. Score < 3: Severe pancreatitis is unlikely. Mortality Risk: Score 0 to 2: 2% mortality Score 3 to 4: 15% mortality Score 5 to 6: 40% mortality Score 7 to 8: 100% mortality Limitations: Can only be completed after 48 hours, though points can be assigned at any time during that 48-hour period. All data points not always obtained. It cannot be repeated on a daily basis. m/ransons-criteriafor-pancreatitismortality APACHE-II The major advantages of the APACHE-II system are the ability to calculate a score on admission and to be updated daily during the hospital course, allowing for monitoring of disease progression and response to therapy. Total score < 8: Morality < 4% Total score 8: Mortality of 11-18% Trajectory of APACHE II score in the first 48 hours is an accurate prognostic indicator as well cores2/apache22.ht ml m/apache-ii-scorefor-icu-mortality BISAP (Bedside Index for Severity in Acute Pancreatitis) A new 5-point scoring system. Compared with APACHE II, BISAP has similar accuracy and is easier to calculate. Blood urea nitrogen level > 25 mg/dl Impaired mental status (GCS < 15) Presence of SIRS Age > 60 years Pleural effusion detected on imaging 1 point is assigned for each variable within 24 hours of presentation for a total score of 0-5. Scores of 3 predict the development of organ failure, persistent organ failure, and necrosis. The higher the score, the higher the mortality rate. Total Score Approximate Mortality 0 0.2% 1 0.6% 2 2% 3 5-8% % % Simple to calculate
10 Appendix 10 Severity Risk Model Calculations (continued) Risk Score Type Notes Scoring Interpretation Link to calculators CT Severity Index Radiological tool that takes into account degree of pancreatic inflammation and the amount of necrosis, the two most important prognostic factors in pancreatitis imaging. A high index of severity is associated with a protracted clinical course, a higher complication rate, and increased mortality. May be more useful after 72 hours, when necrosis becomes more obvious; however, early studies may be indicated if there is uncertainty about the diagnosis or a high degree of clinical suspicion that there may be a significant complication. CT Grade: % Necrosis A 0 0 B 0 1 C < 30% 4 D 30-50% 7 E > 50% 10 Severity Index A score > 5 associated with 8 times risk of death, 17 times more likely to have a prolonged hospital course, and 10 times more likely to require necrosectomy. CT Grade B: 0% necrosis, but shows focal or diffuse enlargement of the pancreas. CTSI of 0-1: No morbidity or mortality CTSI of 2: Morbidity of 4%, no mortality CTSI 7-10%: Mortality 17% Complication rate 92% Advantages of CTSI: Research has shown CTSI of 5 correlated with prolonged hospitalization and higher rates of mortality and morbidity. CTSI 5 associated with a mortality rate 15 times higher than in those with a score of less than 5. No association was found between Ranson s criteria and APACHE II scale scores and mortality or length of hospitalization. Limitations include: Only moderate interobserver correlation, up to 75%. Variable correlation with established clinical scoring systems such as Ranson and APACHE II.
Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.
The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationPathway for the Management of Acute Gallstone Diseases
Pathway for the Management of Acute Gallstone Diseases What s in this document? Pathways to encourage safer, faster and more cost effective management of acute gallstone (GS) disease by stratification
More informationAmerican College of Gastroenterology Guideline: Management of Acute Pancreatitis
PRACTICE GUIDELINES nature publishing group 1 American College of Gastroenterology Guideline: Management of Acute Pancreatitis Scott Tenner, MD, MPH, FACG1, John Baillie, MB, ChB, FRCP, FACG 2, Joh n D
More informationPractice Guidelines in Acute Pancreatitis
American Journal of Gastroenterology ISSN 0002-9270 C 2006 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2006.00856.x Published by Blackwell Publishing Practice Guidelines in Acute Pancreatitis
More informationDiabetic Emergencies. David Hill, D.O.
Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment
More informationPancréatite Aiguë Prise en charge en 2009. L Bühler. Service de Chirurgie Viscérale et Transplantation Département de Chirurgie HUG
Pancréatite Aiguë Prise en charge en 2009 L Bühler Service de Chirurgie Viscérale et Transplantation Département de Chirurgie HUG BACKGROUND Necrotizing acute pancreatitis remains a challenging clinical
More informationAcute Pancreatitis, Diagnosis and Management
Acute Pancreatitis, Diagnosis and Management Tedra D. Gray, BSN, MS, ACNP-BC Sinai Health Systems Internal Medicine Department Division of Gastroenterology Acute Pancreatitis Annual incidence of pancreatitis
More informationPOAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationSepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
More informationAmylase and Lipase Tests
Amylase and Lipase Tests Also known as: Amy Formal name: Amylase Related tests: Lipase The Test The blood amylase test is ordered, often along with a lipase test, to help diagnose and monitor acute or
More informationResearch Article Analysis of the Power of Common Diagnostic Tools in the Management of Acute Pancreatitis
Gastroenterology Research and Practice, Article ID 438697, 4 pages http://dx.doi.org/10.1155/2014/438697 Research Article Analysis of the Power of Common Diagnostic Tools in the Management of Acute Pancreatitis
More informationThe Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
More informationSubject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013
Stony Brook Medicine Severe Sepsis/Septic Shock Recognition and Treatment Protocols Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August
More informationLothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationCore Measures SEPSIS UPDATES
Patricia Walker, RN-BC, BSN Evidence Based Practice Manager Quality Management Services UCLA Health System, Ronald Reagan Medical Center Core Measures SEPSIS UPDATES Sepsis Core Measures Bundle Requirements
More informationHyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
More informationInterpretation of Laboratory Values
Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
One Children s Plaza Dayton, OH 45404-1815 www.childrensdayton.org DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended
More informationAcute abdominal conditions Key Points
7 Acute abdominal conditions Key Points 7.1 ASSESSMENT AND DIAGNOSIS Referred abdominal pain Fore gut pain (stomach, duodenum, gall bladder) is referred to the upper abdomen Mid gut pain (small intestine,
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationSE5h, Sepsis Education.pdf. Surviving Sepsis
Surviving Sepsis 1 Scope and Impact of the Problem: Severe sepsis is a major healthcare problem that affects millions of people around the world each year with an extremely high mortality rate of 30 to
More informationDecreasing Sepsis Mortality at the University of Colorado Hospital
Decreasing Sepsis Mortality at the University of Colorado Hospital Maureen Dzialo, RN, BSN - Nurse Manager, Cardiac Intensive Care Unit Olivia Kerveillant, RN Clinical Nurse III, Medical Intensive Care
More informationGallbladder - gallstones and surgery
Gallbladder - gallstones and surgery Summary Gallstones are small stones made from cholesterol, bile pigment and calcium salts, which form in a person s gall bladder. Medical treatment isn t necessary
More information2002 burns responsible for 322,000 deaths world wide. aboriginal community in NA Most burns occur in the urban environment
Burn Injuries: The Problem 2002 burns responsible for 322,000 deaths world wide 4 th as cause of unintentional child injury death in the USA 3 rd leading cause of unintentional death in aboriginal community
More informationDisability Evaluation Under Social Security
Disability Evaluation Under Social Security Revised Medical Criteria for Evaluating Endocrine Disorders Effective June 7, 2011 Why a Revision? Social Security revisions reflect: SSA s adjudicative experience.
More informationAdult CCRN/CCRN E/CCRN K Certification Review Course: Endocrine 12/2015. Endocrine 1. Disclosures. Nothing to disclose
Adult CCRN/CCRN E/CCRN K Certification Review Course: Carol Rauen RN BC, MS, PCCN, CCRN, CEN Disclosures Nothing to disclose 1 Body Harmony disorders and emergencies Body Harmony (cont) Introduction Disorders
More informationLaboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition
Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition Copy 1 Location of copies Web based only The following guideline is for use by medical staff caring for the patient and members
More informationNUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
More informationAPPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES
APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES The critical care nurse practitioner orientation is an individualized process based on one s previous experiences and should
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationEmergencies in Post- Bariatric Surgery Patients
Emergencies in Post- Patients Disclosures Dr. Birnbaumer has no financial disclosures Diane M. Birnbaumer, M.D., FACEP Professor of Medicine University of California, Los Angeles Senior Clinical Educator
More informationColocutaneous Fistula. Disclosures
Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula
More informationAcute Abdominal Pain following Bariatric Surgery. Disclosure. Objectives 8/17/2015. I have nothing to disclose
Acute Abdominal Pain following Bariatric Surgery Kathy J. Morris, DNP, APRN, FNP C, FAANP University of Nebraska Medical Center College of Nursing Disclosure I have nothing to disclose Objectives Pathophysiology
More informationCardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
More informationEarly Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi
Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the
More information+Severe Sepsis EMS Spearheads the Attack against a Devastating Syndrome
+ +Severe Sepsis EMS Spearheads the Attack against a Devastating Syndrome By Andrew Garlisi MD MPH MBA VAQSF CASE PRESENTATION You are called to the residence of a 74 year-old female who has experienced
More informationMusculoskeletal Infection Care Process Model
Musculoskeletal Infection Care Process Model Musculoskeletal infections are serious and potentially life-threatening. Musculoskeletal infections include necrotizing fasciitis, septic arthritis, osteomyelitis,
More informationAcid-Base Disorders. Jai Radhakrishnan, MD, MS. Objectives. Diagnostic Considerations. Step 1: Primary Disorder. Formulae. Step 2: Compensation
Objectives Diagnostic approach to acid base disorders Common clinical examples of acidoses and alkaloses Acid-Base Disorders Jai Radhakrishnan 1 2 Diagnostic Considerations Data points required: ABG: ph,
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More informationDiabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are
More informationTOTAL PARENTERAL NUTRITION (TPN) Revised January 2013
TOTAL PARENTERAL NUTRITION (TPN) Revised January 2013 OBJECTIVES Definition Indications for TPN administration Composition of TPN solutions Access routes for TPN administration Monitoring TPN administration
More informationLiver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology
Liver, Gallbladder and Pancreas diseases Premed 2 Pathophysiology Pancreas Pancreatitis Acute Pancreatitis Autodigestion of the pancreas due to activation of the enzymes Hemorrhagic fat necrosis, calcium
More informationCARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
More informationGeorgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:
Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: CLINICAL UNIT: ASSIGNMENT DATES: PATIENT (last initial):
More informationLynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures
Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor No disclosures 1 2 3 Discuss data requirements -3 hour bundle -6 hour bundle Challenges and compliance issues Success 4 Based on the Surviving Sepsis
More informationA New Hope For Patients with Mild Gallstone Pancreatitis
RADOMIZED CONTROLLED TRIALS Early Cholecystectomy Safely Decreases Hospital Stay in Patients With Mild Gallstone Pancreatitis A Randomized Prospective Study Armen Aboulian, MD,* Tony Chan, MD,* Arezou
More informationEFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
More informationOpen the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke
Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis
More informationAlcoholic Hepatitis (Teacher s Guide)
Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options
More informationDiane Byrum RN M SN CCRN CCNS FCCM Critical Care Clinical Nurse Specialist Presbyterian Hospital Charlotte, NC
Diane Byrum RN M SN CCRN CCNS FCCM Critical Care Clinical Nurse Specialist Presbyterian Hospital Charlotte, NC PANCREATITIS Pancreas is located in the retroperitoneal space with no capsule..inflammation
More informationHepatocellular Carcinoma (HCC)
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
More informationSepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status
Patient exhibits two or more of the following SIRS criteria: Temperature greater than 38 o C (100.4 o F) or less SIRS than criteria 36 o C (96.8 o F) Heart Rate greater than 90 beats/minute Respiratory
More informationHow To Treat A Diabetic Coma With Tpn
GUIDELINES FOR TOTAL PARENTERAL NUTRITION (TPN) IN ADULT BONE MARROW TRANSPLANT PATIENTS TPN Indications TPN is indicated for any patient who is not expected to eat sufficiently for 3-5 days in severe
More informationAdvanced Practice Provider Academy
(+)Corey M. Slovis, MD, FACEP Professor, Emergency Medicine and Medicine; Chairman, Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Medical Director, Metro
More informationSuffolk County Community College School of Nursing NUR 133 ADULT NURSING I
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB
More informationInpatient Heart Failure Management: Risks & Benefits
Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationLa pancréatite aiguë aux urgences
La pancréatite aiguë aux urgences Marianna Arvanitakis Myriam Delhaye Hopital Erasme ULB Séminaire Urgences, 8/11/2011 F I R S T W E E K F R O M O N S E T Predicted mild disease Acute pancreatitis Diagnosis
More informationDehydration & Overhydration. Waseem Jerjes
Dehydration & Overhydration Waseem Jerjes Dehydration 3 Major Types Isotonic - Fluid has the same osmolarity as plasma Hypotonic -Fluid has fewer solutes than plasma Hypertonic-Fluid has more solutes than
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy. Case Series
ABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy Case Series Summary of Cases: USER EXPERIENCE The ABThera OA NPT system was found by surgeons to be a convenient and effective
More informationOpen Ventral Hernia Repair
Ventral Hernias Open Ventral Hernia Repair UCSF Postgraduate Course in General Surgery Maui, HI March 21, 2011 Hobart W. Harris, MD, MPH Ventral Hernias: National Experience Occur following 11-23% of laparotomies,
More informationBCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )
BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) Protocol Code Tumour Group Contact Physician UGIPNSUNI Gastrointestinal Dr. Hagen
More informationINTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline
Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative
More informationBiliary Stone Disease
Biliary Stone Disease Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm You have
More informationAcid-Base Balance and the Anion Gap
Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very
More informationEndoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009
Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy M. Arvanitakis SRBG June 2009 Outline Antibiotic prophylaxis during endoscopy Upper GI endoscopy Lower
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationBCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)
BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) Protocol Code Tumour Group Contact Physician UGUTIP Genitourinary Dr.
More informationDiabetic Ketoacidosis
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Diabetic Ketoacidosis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should
More informationBile Leaks After Laparoscopic Cholecystectomy. Kings County Hospital Center Eliana A. Soto, MD
Bile Leaks After Laparoscopic Cholecystectomy Kings County Hospital Center Eliana A. Soto, MD Biliary Injuries during Cholecystectomy In the 1990s, high rate of biliary injury was due in part to learning
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationClostridium Difficile Colitis: Treatments, Guidelines, and Challenges
Clostridium Difficile Colitis: Treatments, Guidelines, and Challenges Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma and Acute Care Surgery
More informationOther Causes of Fever
T e c h n i c a l S e m i n a r s Other Causes of Fever Febrile Illness Causes Fever After Seven Days Referral Relapsing Fever - Borreliosis Overview JHR Adaptation Sore Throat Overview Prevention Management
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More informationLeanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN
Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN Learning Outcomes Identify triggers to the IIR. Describe the pathophysiologic changes that
More informationTelemedicine Resuscitation & Arrest Trials (TreAT)
Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine within the ED for treating Severe Sepsis: A Hub and Spoke Telemedicine pilot SUMR Intern: Karole Collier Mentor: Dr. Brendan Carr & Dr. Anish
More informationLAB 12 ENDOCRINE II. Due next lab: Lab Exam 3 covers labs 11 and 12, endocrine chart and endocrine case studies (1-4 and 7).
111 LAB 12 ENDOCRINE II Assignments: Quiz : Endocrine Chart pages 112-114 Due next lab: Lab Exam 3 covers labs 11 and 12, endocrine chart and endocrine case studies (1-4 and 7). Objectives: Review the
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationGuidelines. for Sick Day Management for People with Diabetes
Guidelines for Sick Day Management for People with Diabetes When to Follow Sick Day Guidelines These guidelines apply when the person with diabetes is feeling unwell or noticing signs of an illness and/
More informationLCD for Viral Hepatitis Serology Tests
LCD for Viral Hepatitis Serology Tests Applicable CPT Code(s): 86692 Antibody; Hepatitis, Delta Agent 86704 Hepatitis B Core Antibody (HBcAb); Total 86705 Hepatitis B Core Antibody (HBcAb); IgM Antibody
More informationChronic pancreatitis Questions and answers. Dr. med. Bruno Strebel
Chronic pancreatitis Questions and answers Dr. med. Bruno Strebel Question 1: Chronic pancreatitis What is the definition of chronic pancreatitis? Chronic pancreatitis Questions and answers 2 Question
More informationAdams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS
Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Your health is important to us! The test descriptions listed below are for educational purposes only. Laboratory test interpretation
More informationThe Critically Ill Patient: Surgical Intensive Care. Dr. Thomas VanderLaan Dr. Melanie Walker Huntington Memorial Hospital Pasadena, California
The Critically Ill Patient: Surgical Intensive Care Dr. Thomas VanderLaan Dr. Melanie Walker Huntington Memorial Hospital Pasadena, California Outline Recognizing Critical Illness The Stress Response Systemic
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationMind the Gap: Navigating the Underground World of DKA. Objectives. Back That Train Up! 9/26/2014
Mind the Gap: Navigating the Underground World of DKA Christina Canfield, MSN, RN, ACNS-BC, CCRN Clinical Nurse Specialist Cleveland Clinic Respiratory Institute Objectives Upon completion of this activity
More informationCT scans and IV contrast (radiographic iodinated contrast) utilization in adults
CT scans and IV contrast (radiographic iodinated contrast) utilization in adults At United Radiology Group, a majority of CT exams are performed either with IV contrast or without while just a few exams
More informationGuideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
More informationThe Anorexic Cat For this reason, any cat that stops eating for any reason is considered an emergency situation.
The Anorexic Cat Introduction Any cat that stops eating (anorexic) or begins to eat much less than their normal amount should be seen by a veterinarian right away. The primary reason why a cat stops eating
More informationACID- BASE and ELECTROLYTE BALANCE. MGHS School of EMT-Paramedic Program 2011
ACID- BASE and ELECTROLYTE BALANCE MGHS School of EMT-Paramedic Program 2011 ACID- BASE BALANCE Ions balance themselves like a see-saw. Solutions turn into acids when concentration of hydrogen ions rises
More informationApplying the 2016 ASPEN/ SCCM Critical Care Guidelines to Your Practice. Susan Brantley, MS, RD, LDN
Applying the 2016 ASPEN/ SCCM Critical Care Guidelines to Your Practice Susan Brantley, MS, RD, LDN Objectives: Upon completion of this presentation, participants should be able to: 1. Distinguish the
More information11/10/2014. I have nothing to Disclose. Covered Stents discussed are NOT FDA approved for the indications covered in my presentation
I have nothing to Disclose Ramsey Dallal, MD, FACS Vice Chair Department of Surgery Chief Bariatric i and Minimally i Invasive Surgery Einstein Healthcare Network Nemacolin, PA 2014 Covered Stents discussed
More informationUSC Pediatric Residency Program Quality Improvement Pre-Program Self Assessment
USC Pediatric Residency Program Quality Improvement Pre-Program Self Assessment 1. Have you had previous experience in quality improvement (QI)? Yes No 2. How many formal quality improvement projects have
More informationEXECUTIVE BLOOD WORK PANEL
EXECUTIVE BLOOD WORK PANEL Below is a list of all blood and urine testing done on the day of your Executive Medical. MALE Serum Glucose Random Serum Glucose Fasting Creatinine Uric Acid Sodium Potassium
More information